Janssen and partners seek to develop treatments for dengue fever

08/29/2013 | Reuters

Johnson & Johnson's Janssen Pharmaceuticals agreed to team up with researchers from the University of Leuven in Belgium and the Wellcome Trust charity to develop treatments for dengue fever. The collaboration will focus on a series of compounds that have been shown to block dengue virus replication. The deal includes upfront payment as well as potential milestone fees and royalties.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ